 - Patients with history or evidence upon physical examination of CNS disease, including primary brain tumor, seizures not controlled with standard medical therapy, any brain metastases, or history of cerebrovascular accident CVA, stroke, transient ischemic attack TIA or subarachnoid hemorrhage within 6 months of the first date of treatment on this study. 